Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 1/7/2020
SIETES contiene 93059 citas

 1 a 20 de 153 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Addis A, Ganazzani A, Trotta MP, Magrini N, for the Italian Medicines Agency Scientific Committee and COVID-19 Crisis Unit. Promoting better clinical trials and drug information as public health interventions for the COVID-19 emergency in Italy. Ann Intern Med 2020:16 de junio. [Ref.ID 103673]
2. Cita con resumen
Iacobucci G. Sixty seconds on . . . the RECOVERY trial. BMJ 2020;369:20 de abril. [Ref.ID 103597]
3. Cita con resumen
Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. “Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ 2019;367:12 de diciembre. [Ref.ID 103224]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Pacurariu A, Plueschke K, Olmo CA, Kurz X. Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators. Pharmacoepidemiol Drug Saf 2018;27:julio. [Ref.ID 102879]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Bouvy JC, Blake K, Slattery J, De Bruin ML, Arlett P, Kurz X. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005–2013. Pharmacoepidemiol Drug Saf 2017;26:26 de marzo. [Ref.ID 101903]
6.Tiene citas relacionadas Cita con resumen
Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KAO, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Prevalence, characteristics, and publication of discontinued randomized trials . JAMA 2014;311:1045-52. [Ref.ID 97229]
8. Cita con resumen
Humphreys K, Maisel NC, Blodgett JC, Fuh IL, Finney JW. Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010. JAMA Intern Med 2013;173:1029-31. [Ref.ID 95615]
9. Cita con resumen
Yong E. TRIALS AT THE READY. Preparing for the next pandemic. BMJ 2012;344:21-3. [Ref.ID 93218]
10. Cita con resumen
Watts G. Why the exclusion of older people from clinical research must stop. BMJ 2012;344:23-4. [Ref.ID 93005]
11. Cita con resumen
Kuehn BM. Clinical trials website. JAMA 2012;307:1243. [Ref.ID 92571]
12. Cita con resumen
van Staa TP, Goldacre B, Gulliford M, Cassell J, Pirmohamed M, Taweel A, Delaney B, Smeeth L. Pragmatic randomised trials using routine electronic health records. BMJ 2012;344:22-5. [Ref.ID 92355]
Wendler D. How to enroll participants in research ethically. JAMA 2011;305:1587-8. [Ref.ID 90415]
14. Cita con resumen
Bristol N. US reviews human trial participant protections. Lancet 2010;376:1975-6. [Ref.ID 89856]
15. Cita con resumen
Caldwell PHY, Hamilton S, Tan A, Craig JC. Strategies for increasing recruitment to randomised controlled trials:systematic reviews. PLOS Medicine 2010;7:1000368. [Ref.ID 89706]
16. Cita con resumen
Woodcock J, Sharfstein JM, Hamburg M. Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. N Engl J Med 2010;363:1489-91. [Ref.ID 89056]
17. Cita con resumen
Young RC. Cancer clinical trials - A chronic but curable crisis. N Engl J Med 2010;363:306-9. [Ref.ID 88945]
18. Cita con resumen
Kmietowicz Z. Regulations on medical research need to be reinterpreted. BMJ 2010;340:1160-1. [Ref.ID 88625]
19. Cita con resumen
Relton C, Torgerson D, O'Cathain A, Nicholl J. Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ 2010;340:963-7. [Ref.ID 88489]
20. Cita con resumen
Godlee F, Chalmers I. Information about ongoing clinical trials for patients. BMJ 2010;340:456-7. [Ref.ID 87987]
Seleccionar todas
 1 a 20 de 153 siguiente >>